(R)-(((quinoline-4-carbonyl)-D-alanyl)pyrrolidin-2-yl)boronic acid is a highly promising pharmacophore that can be used to develop PET imaging agents with superior pharmacokinetics properties and excellent imaging contrasts for visualization of FAP-overexpressing carcinomas. The gene discussed is FAP; the disease is carcinoma.